Aardvark Therapeutics, Inc.
AARD · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary
1 Item 1A. Risk Factors 40 Item 1B. Unresolved Staff Comments 99 Item 1C. Cybersecurity 99 Item 2. Properties 101 Item 3. Legal Proceedings 101 Item 4. Mine Safety Disclosures 101 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 102 Item 6. [Reserved] 102 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 103 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 113 ...
Next Earnings
Q2 FY2026 — expected 2026-09-08
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | AARD | discussed_in_filing Cybersecurity | |
| topic_mention | AARD | discussed_in_filing Cybersecurity | |
| topic_mention | AARD | discussed_in_filing Cybersecurity | |
| topic_mention | AARD | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-03-23 | 2025-12-31 | 0001193125-26-119770 | EDGAR | 120K words |
| 2025-03-31 | 2024-12-31 | 0000950170-25-047835 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-13 | 2025-09-30 | 0001193125-25-280260 | EDGAR | 73K words |
| 2025-08-13 | 2025-06-30 | 0000950170-25-108116 | EDGAR | — |
| 2025-05-14 | 2025-03-31 | 0000950170-25-071560 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-03-24 | 0001193125-26-120164 | EDGAR | 1K words |
| 2026-03-23 | 0001193125-26-119727 | EDGAR | — |
| 2026-02-27 | 0001193125-26-082787 | EDGAR | — |
| 2026-02-12 | 0001193125-26-047757 | EDGAR | — |
| 2026-02-10 | 0001193125-26-043764 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009862 | EDGAR | — |
| 2025-12-10 | 0001193125-25-314364 | EDGAR | — |
| 2025-11-13 | 0001193125-25-280235 | EDGAR | — |
| 2025-11-06 | 0001193125-25-267402 | EDGAR | — |
| 2025-11-04 | 0001193125-25-264748 | EDGAR | — |
26 total filings indexed. 11 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001774857 |
| Ticker | AARD |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 655ba9dd20804e49476a79c93a2e996f765dd2c8c4c8770e714b80dc0de350b1
parent: 20110d25f8ffdd5ce72446579f25b301a6c01bd8ca6c9ba04c0a7c93cc288703
content hash: 5d58f3b3568d5562a2998b16ad309322e17f95350f01392d01b84aa4eda8c307
signed: 2026-04-13T04:43:24.388Z
sources: 5 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf